Oncological emergencies - Management guidelines for clinicians

Journal of the Indian Medical Association

Volumn 103, Issue 9, 2005, Pages 474-478

  Bhuyan, C ^a   Saikia, B J ^a   Choudhury, Nandini ^a  

^a A Unit of Tata Memorial Centre   (India)

Author keywords

Infection; Neutropenia; Oncologic emergency; Raised intracranial pressure; Spinal cord compression; Superior vena cava syndrome; Tumour lysis syndrome

Indexed keywords

ALLOPURINOL; ALUMINUM HYDROXIDE; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTICONVULSIVE AGENT; BETA LACTAM; BISPHOSPHONIC ACID DERIVATIVE; CEFEPIME; CEFTAZIDIME; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IFOSFAMIDE; IMIPENEM; MANNITOL; MEROPENEM; RASBURICASE; VANCOMYCIN;

ARTICLE; BONE MARROW DISEASE; EMERGENCY CARE; FEBRILE NEUTROPENIA; HEMORRHAGIC CYSTITIS; HUMAN; HYPERCALCEMIA; HYPERURICEMIA; HYPONATREMIA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; INTRACRANIAL HYPERTENSION; NEUTROPENIC ENTEROCOLITIS; PHYSICIAN; PRACTICE GUIDELINE; SPINAL CORD COMPRESSION; SUPERIOR CAVA VEIN SYNDROME; THROMBOCYTOPENIA; TUMOR LYSIS SYNDROME;

EID: 33144459381     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schinder N, Vogelzang RL - Superior vena cava syndrome: experience with endovascular stents and surgical therapy. Surg Clin North Am 1999; 79: 683-94.
2. Bell DR, Woods RL, Levi JA - Superior vena caval obstruction: a 10-year experience. Med J Aust 1986; 145: 566-8.
3. Schraufnagel DE, Hill R, Leech JA, Pare JA - Superior vena caval obstruction: is it a medical emergency? Am J Med 1981; 70: 1169-74.
4. Yahalom J - Superior vena cava syndrome. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer, Principles & Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005: 2273-80.
5. Helweg-Larsen S, Sorensen PS, Kreiner S - Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000; 46: 1163-9.
6. Dunlay RW, Camp MA, Allon M, Fanti P, Malluche HH, Llach F - Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome. Ann Intern Med 1989; 110: 162-4.
7. Annemans L, Moeremans K, Lamotte M, Conde JG, Berg H, Myint H, et al - Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Support Care Cancer 2003; 11: 249-57.
8. Yim BT, Sims-McCallum RP, Chong PH - Rasburicase for the treatment and prevention of hyperuricemia. Ann Pharmacother 2003; 37: 1047-54.
9. Berghmans T, Paesmans M, Body JJ - A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer 2000; 8: 192-7.
10. De Vita VT Jr, Hellman S, Rosenberg SA, editors - Cancer: Principles & Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
11. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al - 2002 guidelines for the use of antimicrobial, agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
12. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG - Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101-11.
13. Sloas MM, Flynn PM, Kaste SC, Patrick CC - Typhilitis in children with cancer: a 30-year experience. Clin Infect Dis 1993; 17: 484-90.
14. Kimura M, Tomita Y, Morishita H, Takahashi K - Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high dose cyclophosphamide: possible significance of cystoscopy on preventing development of cyclophosphamide induced hemorrhagic cystitis. Urol Int 1998; 61: 8-11.